Status:
TERMINATED
Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit
Lead Sponsor:
Medical University of Vienna
Conditions:
Critical Illness
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Platelets play a central part not just in homeostasis and thrombosis as the primary effector cells, but they are also key cells in the regulation of the immunological response to various stressors. Af...
Eligibility Criteria
Inclusion
- patients admitted to an intensive care unit
- \>18 years of age
Exclusion
- known allergy of intolerance to acetylsalicylic acid
- recent surgery or planned surgery
- active bleeding
- known coagulation disorders
- discretion of the physician
- terminal illness (anticipated life expectancy \<3months; e.g. due to cancer)
- platelet count \<20 000
- recent ulcera
- recent gastrointestinal bleeding
- pregnancy
Key Trial Info
Start Date :
November 15 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 10 2017
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT02285153
Start Date
November 15 2011
End Date
November 10 2017
Last Update
December 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Hospital
Vienna, Austria, 1090